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Liposomes can overcome many of the problems associated with other systems used in therapy, such as those 
involving solubility, pharmacokinetics, in vivo stability and toxicity. However, this system still presents some issues 
for in vivo application, namely its recognition and capture by the immune system and also the location in therapeutic 
sites for drug release. In order to overcome these problems, magneto-sensitive liposomes (magnetoliposomes) have 
been proposed. The magnetic components allow concentration of the liposomes in the desired area of the patient’s 
organs by magnetic forces, often augmented by magnetic agglomeration. This way, a new therapy emerges, 
involving the guided transport of biologically active substances, most of them toxic and with systemic side effects 
[1,2]. In therapy, the most promising applications of magnetoliposomes are magnetic guided drug delivery and 
hyperthermia [1,2]. 
Considering their biocompatibility, calcium ferrite nanoparticles were prepared and characterized. The structural 
and magnetic properties of the nanoparticles were evaluated by XRD, TEM and SQUID. The synthesized 
nanoparticles were either entrapped in liposomes, originating aqueous magnetoliposomes (AMLs), or covered with a 
lipid bilayer, forming solid magnetoliposomes (SMLs) [3-5]. Magnetoliposomes present average diameters around 
150 nm, suitable for biomedical applications (Fig. 1). Membrane fusion between magnetoliposomes and GUVs (giant 
unilamellar vesicles), used as models of cell membranes, was confirmed by FRET (Förster Resonance Energy 
Transfer) assays. 
The magnetoliposomes were loaded with new potential anticancer drugs, thienopyridine derivatives (Fig. 2), with 
a strong antitumor activity against breast cancer cells [6]. Fluorescence anisotropy measurements indicate that the 
new antitumor drugs are mainly located in the lipid membrane of the magnetic liposomes. These results point to a 
promising application of magnetoliposomes in oncological therapy, simultaneously as hyperthermia agents and as 
nanocarriers for antitumor drugs.  
 
Fig. 1: Average diameter of AMLs containing calcium 
ferrite nanoparticles obtained by DLS (three 
independent measurements). 
 
Fig. 2: Schematic representation of an aqueous 
magnetoliposome loaded with an antitumor 
thienopyridine derivative. 
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